News - India

Filter

Current filters:

India

Popular Filters

1 to 25 of 93 results

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

Indian generic drugmakers set to score from MPP deals on HIV drugs

Indian generic drugmakers set to score from MPP deals on HIV drugs

28-07-2014

Seven new sub-licensing agreements for the manufacture of generic HIV medicines and two new generation…

Anti-viralsGenericsIndiaLicensingPatentsProduction

Glenmark reports strong growth everywhere but the USA

Glenmark reports strong growth everywhere but the USA

25-07-2014

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20%…

FinancialGenericsGlenmark PharmaceuticalsIndia

Medicines Patent Pool broadens collaboration with Gilead Sciences

24-07-2014

The Medicines Patent Pool (MPP) has entered into a new licensing agreement with US biotech firm Gilead…

Anti-viralsChinaGenericsGilead SciencesIndiaLicensingProductiontenofovir alafenamide

Elder to strengthen existing brands following sale to Torrent

Elder to strengthen existing brands following sale to Torrent

18-07-2014

Indian drugmaker Elder Pharma has said it plans to strengthen its existing brands including Eldervit…

Elder PharmaceuticalsFinancialIndiaPharmaceuticalTorrent GroupTorrent Pharmaceuticals

Strides Arcolab makes strategic investment in Oncobiologics

Strides Arcolab makes strategic investment in Oncobiologics

16-07-2014

India’s Strides Arcolab has made a series of strategic investments in Oncobiologics, a privately held…

BiosimilarsBiotechnologyFinancialIndiaMergers & AcquisitionsOncobiologicsStrides Arcolab

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence

16-07-2014

Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, revealed that it has…

BSE SensexEconomy of IndiaGenericsIndiaMergers & AcquisitionsPharmalucenceProductionRanbaxy LaboratoriesSun Pharmaceuticals

Packaging and delivery specialist West opens first plant in India

Packaging and delivery specialist West opens first plant in India

16-07-2014

US packaging and delivery company West has dedicated its manufacturing plant in the Sri City Special…

ChennaiIndiaPharmaceuticalProductionSri CityWest

Multinational and Indian drugmakers to face another price cap

Multinational and Indian drugmakers to face another price cap

15-07-2014

In a major blow to drug companies, India's National Pharmaceutical Pricing Authority (NPPA) has decided…

IndiaNational Pharmaceutical Pricing AuthorityPharmaceuticalPricing

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

Hospira completes buy of Orchid's API production and R&D facility

Hospira completes buy of Orchid's API production and R&D facility

06-07-2014

US provider of injectable drugs and infusion technologies Hospira says it has completed the acquisition…

GenericsHospiraIndiaMergers & AcquisitionsOrchid Chemicals & PharmaceuticalsProduction

Indian generics sector hires India First Group to re-establish its reputation

Indian generics sector hires India First Group to re-establish its reputation

01-07-2014

USA-based generic drugmakers want high quality, low cost generic pharmaceuticals made in India and the…

GenericsHealthcareIndiaPricingUSA

Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen

30-06-2014

Cipla has collaborated with fellow Indian drugmaker Hetero to launch a biosimilar of the drug darbepoetin…

ActoriseAmgenAranespBiosimilarsCiplaGenericsHeteroIndiaMarkets & MarketingMergers & AcquisitionsOncologyRest of the World

Further Indian drug price cuts, and price control categorization likely

30-06-2014

In order to make drugs more affordable to the country’s public, the Indian government is likely to…

FinancialIndiaPharmaceuticalPoliticsPricing

Intas reinforces cancer range with the first time launch of Azadine in India

25-06-2014

Indian drugmaker Intas Pharmaceuticals says it has reinforced its oncology product range by successfully…

AzadineCelgeneGenericsIndiaIntas PharmaceuticalsMarkets & MarketingOncologyVidaza

New drug prices in India to be capped by NPPA

New drug prices in India to be capped by NPPA

16-06-2014

In order to keep a lid on the escalating cost of drugs, India's drug price regulator has decided to fix…

IndiaMachineryNatco PharmaPharmaceuticalPharmacyPoliticsPricingRetail priceSun Pharmaceuticals

Indian draft guidelines for clinical trial compensation for medical management

Indian draft guidelines for clinical trial compensation for medical management

10-06-2014

India's Ministry of Health has released new and revised draft guidelines on compensation to be paid for…

FinancialIndiaPharmaceuticalResearch

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

05-06-2014

European regulatory authorities have finalized their assessment of reported non-compliance with Good…

EuropeGenericsIndiaProductionRanbaxy LaboratoriesRegulation

Bristol-Myers Squibb extends research accord with Biocon unit Syngene

Bristol-Myers Squibb extends research accord with Biocon unit Syngene

05-06-2014

US pharma major Bristol-Myers Squibb and Syngene International, India’s largest contract research organization,…

BioconBiotechnologyBristol-Myers SquibbIndiaResearchSyngene

Glenmark opens new MAb manufacturing site in Switzerland

Glenmark opens new MAb manufacturing site in Switzerland

04-06-2014

Glenmark Pharmaceuticals SA (GPSA), a wholly-owned subsidiary of India’s Glenmark Pharmaceuticals,…

AnalgesiaEuropeGlenmark PharmaceuticalsIndiaMonoclonal antibodiesPharmaceuticalProduction

BRIC nations identified as emerging leaders in global clinical trials landscape

BRIC nations identified as emerging leaders in global clinical trials landscape

28-05-2014

Despite challenges, increasing health care budgets and advancing markets in BRIC (Brazil, Russia, India…

BrazilChinaIndiaPharmaceuticalResearchRussia

1 to 25 of 93 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top